Anti-OBSCN/ ARHGEF30/ UNC89 monoclonal antibody
Anti-OBSCN/ ARHGEF30/ UNC89 antibody for FACS & in-vivo assay
Go to OBSCN/OBSCN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP2222-Ab-1/ GM-Tg-hg-MP2222-Ab-2 | Anti-Human OBSCN monoclonal antibody | Human |
GM-Tg-rg-MP2222-Ab-1/ GM-Tg-rg-MP2222-Ab-2 | Anti-Rat OBSCN monoclonal antibody | Rat |
GM-Tg-mg-MP2222-Ab-1/ GM-Tg-mg-MP2222-Ab-2 | Anti-Mouse OBSCN monoclonal antibody | Mouse |
GM-Tg-cynog-MP2222-Ab-1/ GM-Tg-cynog-MP2222-Ab-2 | Anti-Cynomolgus/ Rhesus macaque OBSCN monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP2222-Ab-1/ GM-Tg-felg-MP2222-Ab-2 | Anti-Feline OBSCN monoclonal antibody | Feline |
GM-Tg-cang-MP2222-Ab-1/ GM-Tg-cang-MP2222-Ab-2 | Anti-Canine OBSCN monoclonal antibody | Canine |
GM-Tg-bovg-MP2222-Ab-1/ GM-Tg-bovg-MP2222-Ab-2 | Anti-Bovine OBSCN monoclonal antibody | Bovine |
GM-Tg-equg-MP2222-Ab-1/ GM-Tg-equg-MP2222-Ab-2 | Anti-Equine OBSCN monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP2222-Ab-1/ GM-Tg-hg-MP2222-Ab-2; GM-Tg-rg-MP2222-Ab-1/ GM-Tg-rg-MP2222-Ab-2; GM-Tg-mg-MP2222-Ab-1/ GM-Tg-mg-MP2222-Ab-2; GM-Tg-cynog-MP2222-Ab-1/ GM-Tg-cynog-MP2222-Ab-2; GM-Tg-felg-MP2222-Ab-1/ GM-Tg-felg-MP2222-Ab-2; GM-Tg-cang-MP2222-Ab-1/ GM-Tg-cang-MP2222-Ab-2; GM-Tg-bovg-MP2222-Ab-1/ GM-Tg-bovg-MP2222-Ab-2; GM-Tg-equg-MP2222-Ab-1/ GM-Tg-equg-MP2222-Ab-2 |
Products Name | Anti-OBSCN monoclonal antibody |
Format | mab |
Target Name | OBSCN |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-OBSCN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species OBSCN/ ARHGEF30/ UNC89 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP2222 |
Target Name | OBSCN |
Gene ID | 84033,380698,338458,694413,482206,101101539,537193,100146449 |
Gene Symbol and Synonyms | ARHGEF30,Gm878,OBSCN,RGD1305774,RHABDO1,UNC89 |
Uniprot Accession | Q5VST9 |
Uniprot Entry Name | OBSCN_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Mucocutaneous lymph node syndrome [Kawasaki] |
Gene Ensembl | ENSG00000154358 |
Target Classification | N/A |
The target: OBSCN, gene name: OBSCN, also named as ARHGEF30, UNC89. The obscurin gene spans more than 150 kb, contains over 80 exons and encodes a protein of approximately 720 kDa. The encoded protein contains 68 Ig domains, 2 fibronectin domains, 1 calcium/calmodulin-binding domain, 1 RhoGEF domain with an associated PH domain, and 2 serine-threonine kinase domains. This protein belongs to the family of giant sacromeric signaling proteins that includes titin and nebulin, and may have a role in the organization of myofibrils during assembly and may mediate interactions between the sarcoplasmic reticulum and myofibrils. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.